Literature DB >> 3883281

Immunohistochemical demonstration of neuronal and astrocytic differentiation in retinoblastoma.

E P Messmer, R L Font, J B Kirkpatrick, W Höpping.   

Abstract

Sections of 51 surgically enucleated eyes from cases of retinoblastomas were examined immunohistochemically to delineate patterns of cellular differentiation. Employing the avidin-biotin immunoperoxidase technique, antibodies were used against glial fibrillary acidic protein (GFAP), S-100 protein and neuron specific enolase (NSE). Areas of uninvolved retina and/or optic nerve were used as built-in positive control. Most of the tumors showed GFAP and S-100 protein-positive perivascular glial cells that were interpreted as reactive astrocytes. In three well-differentiated retinoblastomas, glial cells were found to be interspersed randomly among tumor cells and not associated with blood vessels. These glial cells were interpreted as neoplastic based on their distribution pattern and cytologic features. In about half of the tumors, the retinoblastoma cells stained positively for NSE, indicating their neuronal tumor cells that stained positively for NSE but failed to show any evidence of photoreceptor differentiation. Based on these observations and similar differentiation patterns described in other primitive neuroectodermal tumors of the brain, it is suggested that retinoblastoma cells can differentiate not only into photoreceptor cells but also along other neuronal cell lines and rarely into glial cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3883281     DOI: 10.1016/s0161-6420(85)34076-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

1.  Retinoblastoma and retinal astrocytoma: unusual double tumour in one eye.

Authors:  S M Imhof; A C Moll; P Van Der Valk; A Y N Schouten-Van Meeteren
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

Review 2.  Histogenesis of retinoblastoma.

Authors:  J Hungerford
Journal:  Br J Ophthalmol       Date:  1990-03       Impact factor: 4.638

Review 3.  Applications of monoclonal antibodies in the investigation, diagnosis, and treatment of retinoblastoma.

Authors:  J F Tarlton; D L Easty
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

4.  Neuronal and glial properties of a murine transgenic retinoblastoma model.

Authors:  T Kivelä; I Virtanen; D M Marcus; J M O'Brien; J L Carpenter; E Brauner; A Tarkkanen; D M Albert
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

5.  Glycoconjugates in retinoblastoma. A lectin histochemical study of ten formalin-fixed and paraffin-embedded tumours.

Authors:  T Kivelä
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

6.  Immunohistochemical demonstration of glial markers in retinoblastomas.

Authors:  H D Schrøder
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

7.  Immunohistochemical evidence of neuronal and glial differentiation in retinoblastoma.

Authors:  K P Xu; S L Liu; C Ni
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

Review 8.  Expression of developmentally defined retinal phenotypes in the histogenesis of retinoblastoma.

Authors:  F Gonzalez-Fernandez; M B Lopes; J M Garcia-Fernandez; R G Foster; W J De Grip; S Rosemberg; S A Newman; S R VandenBerg
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

9.  Immunohistological characterisation of retinoblastoma and related ocular tissue.

Authors:  J F Tarlton; D L Easty
Journal:  Br J Ophthalmol       Date:  1990-03       Impact factor: 4.638

10.  Neuroblastic differentiation potential of the human retinoblastoma cell lines Y-79 and WERI-Rb1 maintained in an organ culture system. An immunohistochemical, electron microscopic, and biochemical study.

Authors:  M M Herman; E Perentes; C D Katsetos; F Darcel; A Frankfurter; V P Collins; L A Donoso; L F Eng; P J Marangos; A F Wiechmann
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.